Dr Fraser Murray joins as VP Pre-Clinical Development

Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation and dermatology. Together with Dr Timothy Schulz-Utermoehl, he will be responsible for three pre-clinical research programmes recently acquired by Chronos. Read the press release.